Novartis’ Sandoz division is to provide generic medicines and biosimilars in Vietnam at-cost for the treatment of severe COVID-19 symptoms, under a memorandum of understanding signed between Novartis and Vietnam’s Ministry of Health.
Signed at the recent Switzerland-Vietnam Business Summit in Bern, to mark the 50th anniversary of the establishment of diplomatic relations between the two countries, the memorandum is part of several solutions Novartis is providing to help low- and
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?